Organogenesis Holdings Inc. (NASDAQ:ORGO) has a beta value of 1.43 and has seen 1,017,633 shares traded in the last trading session. The company, currently valued at $2.86 Billion, closed the last trade at $22.36 per share which meant it gained $1.05 on the day or 4.93% during that session. The ORGO stock price is -3.71% off its 52-week high price of $23.19 and 87.21% above the 52-week low of $2.86. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.48 Million shares traded. The 3-month trading volume is 890.8 Million shares.
The consensus among analysts is that Organogenesis Holdings Inc. (ORGO) is a Buy stock at the moment, with a recommendation rating of 1.2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 4 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.02.
Organogenesis Holdings Inc. (NASDAQ:ORGO) trade information
Sporting 4.93% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, Apr 30 when the ORGO stock price touched $23.21- or saw a rise of 3.66%. Year-to-date, Organogenesis Holdings Inc. shares have moved 196.95%, while the 5-day performance has seen it change 1.41%. Over the past 30 days, the shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) have changed 23.06%. Short interest in the company has seen 2.3 Million shares shorted with days to cover at 0.
Wall Street analysts have a consensus price target for the stock at $24.25, which means that the shares’ value could jump 8.45% from current levels. The projected low price target is $21 while the price target rests at a high of $27. In that case, then, we find that the current price level is +20.75% off the targeted high while a plunge would see the stock lose -6.08% from current levels.
Organogenesis Holdings Inc. (ORGO) estimates and forecasts
Figures show that Organogenesis Holdings Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +515.98% over the past 6 months, with this year growth rate of -31.25%, compared to 16.6% for the industry. Other than that, the company has, however Increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 87.5% and 140% for the next quarter. Revenue growth from the last financial year stood is estimated to be +17.4%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +199.9% over the past 5 years. Earnings growth for 2021 is a modest +136.4% while over the next 5 years, the company’s earnings are expected to increase by 44.46%.
Organogenesis Holdings Inc. (NASDAQ:ORGO)’s Major holders
Insiders own 54.82% of the company shares, while shares held by institutions stand at 41.17% with a share float percentage of 91.12%. Investors are also buoyed by the number of investors in a company, with Organogenesis Holdings Inc. having a total of 117 institutions that hold shares in the company. The top two institutional holders are Avidity Partners Management, LP with over 5.52 Million shares worth more than $41.58 Million. As of December 30, 2020, Avidity Partners Management, LP held 4.31% of shares outstanding.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The other major institutional holder is Prosight Management, LP, with the holding of over 2.02 Million shares as of December 30, 2020. The firm’s total holdings are worth over $15.24 Million and represent 1.58% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Financial Investors Tr-Emerald Growth Fund and Vanguard Extended Market Index Fund. As of January 30, 2021, the former fund manager holds about 1.44% shares in the company for having 1846153 shares of worth $19.31 Million while later fund manager owns 739.15 Thousand shares of worth $5.57 Million as of December 30, 2020, which makes it owner of about 0.58% of company’s outstanding stock.